Targeted therapies for cancer during the COVID-19 pandemic: a threat or a blessing?

Moujaess, Elissar; Kourie, Hampig Raphael; Kattan, Joseph

Moujaess, Elissar; Kourie, Hampig Raphael; Kattan, Joseph.

Moujaess E; Department of Hematology & Oncology, Faculty of Medicine, Saint Joseph University, Beirut, 17-5208, Lebanon.
Kourie HR; Department of Hematology & Oncology, Faculty of Medicine, Saint Joseph University, Beirut, 17-5208, Lebanon.
Kattan J; Department of Hematology & Oncology, Faculty of Medicine, Saint Joseph University, Beirut, 17-5208, Lebanon.

Pharmacogenomics ; 21(11): 731-733, 2020 07.

Article in English | MEDLINE | ID: covidwho-592044

Subject(s)

Betacoronavirus; Coronavirus Infections; Neoplasms; Pandemics; Pneumonia, Viral; COVID-19; Humans; SARS-CoV-2

Keywords

COVID-19; SARS-CoV-2; cancer; neoplasm; targeted therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Betacoronavirus / Neoplasms Limits: Humans Language: English Journal: Pharmacogenomics Journal subject: Pharmacology / Genetics, Medical Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google